Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants

Data is lacking on the effect of continuous intravenous sildenafil treatment in preterm infants with early pulmonary hypertension (PH), especially in very low birth weight (VLBW) infants. Preterm infants (< 37 weeks of gestational age) with intravenous sildenafil treatment and diagnosis of PH bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Lukas, Monno, Paulina, Strizek, Brigitte, Dresbach, Till, Mueller, Andreas, Kipfmueller, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209068/
https://www.ncbi.nlm.nih.gov/pubmed/37225769
http://dx.doi.org/10.1038/s41598-023-35387-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209068/
https://www.ncbi.nlm.nih.gov/pubmed/37225769
http://dx.doi.org/10.1038/s41598-023-35387-y

Ejemplares similares